Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

nice_reception

Bavencio+Inylta combo approved or Cancer Drugs Fund in advanced renal cell carcinoma

July 31, 2020 Medical Communications, Sales and Marketing Merck, NICE, Pfizer, pharma

NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as …
News

Takeda poised to cut sales jobs in Japan as restructuring continues

July 29, 2020 Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, job cuts

Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

July 29, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …
News
glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020 Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …
News
indianapolis

Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis

July 24, 2020 Medical Communications Eli Lilly, Humalog, diabetes, insulin

Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …
News

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020 Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …
News
stsock_frugu

Brazilian study finds hydroxychloroquine is not effective at treating COVID-19

July 24, 2020 Medical Communications COVID-19, coronavirus, hydroxychloroquine, pandemic

Another study has shown hydroxychloroquine is ineffective in treating the coronavirus. The research was published in the New England Journal …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
News
meekey

David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals

July 23, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …
Appointment
novavax

Executives at Novavax expected to get big payouts, even if their vaccine fails clinical trials

July 23, 2020 Medical Communications, Sales and Marketing COVID Vaccine, Vaccine, coronavirus

Novavax, one of the leading US firms which is developing a coronavirus vaccine, is set to award executives stock options …
News

Is Pharma doing enough on sustainability?

July 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
Feature

Innate Pharma announces new Executive Vice President and Chief Medical Officer

July 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Innate Pharma, appointment

Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …
Appointment
astrazeneca_sign_sky

AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks

July 17, 2020 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track

AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …
News
800px-smallpox_vaccine

WHO reports “alarming decline” in child vaccinations due to COVID-19 disruption

July 17, 2020 Medical Communications, Sales and Marketing COVID-19, WHO, vaccination, vaccines

The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential …
News
fda

FDA grants fast review for Bayer and MSD’s heart failure drug vericiguat

July 17, 2020 Medical Communications Bayer, FDA, MSD

The FDA has granted a fast Priority Review for Bayer and MSD’s heart failure drug vericiguat. This was based on …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026